GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (LUX:ONEA) » Definitions » Cyclically Adjusted PB Ratio

Oneness Biotech Co (LUX:ONEA) Cyclically Adjusted PB Ratio : 6.90 (As of Jun. 09, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Oneness Biotech Co Cyclically Adjusted PB Ratio?

As of today (2024-06-09), Oneness Biotech Co's current share price is $23.40. Oneness Biotech Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $3.39. Oneness Biotech Co's Cyclically Adjusted PB Ratio for today is 6.90.

The historical rank and industry rank for Oneness Biotech Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

LUX:ONEA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.72   Med: 11.22   Max: 31.37
Current: 7

During the past years, Oneness Biotech Co's highest Cyclically Adjusted PB Ratio was 31.37. The lowest was 1.72. And the median was 11.22.

LUX:ONEA's Cyclically Adjusted PB Ratio is ranked worse than
84.72% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs LUX:ONEA: 7.00

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Oneness Biotech Co's adjusted book value per share data for the three months ended in Mar. 2024 was $4.785. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.39 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Oneness Biotech Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Oneness Biotech Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co Cyclically Adjusted PB Ratio Chart

Oneness Biotech Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.37 17.16 16.18 11.37

Oneness Biotech Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.37 11.87 10.61 8.32 8.02

Competitive Comparison of Oneness Biotech Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Oneness Biotech Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oneness Biotech Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oneness Biotech Co's Cyclically Adjusted PB Ratio falls into.



Oneness Biotech Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Oneness Biotech Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=23.40/3.39
=6.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oneness Biotech Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Oneness Biotech Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.785/131.7762*131.7762
=4.785

Current CPI (Mar. 2024) = 131.7762.

Oneness Biotech Co Quarterly Data

Book Value per Share CPI Adj_Book
201403 1.686 99.695 2.229
201406 1.809 100.560 2.371
201409 1.686 100.428 2.212
201412 1.573 99.070 2.092
201503 2.294 99.621 3.034
201506 1.970 100.684 2.578
201509 1.896 100.392 2.489
201512 1.897 99.792 2.505
201603 1.860 100.470 2.440
201606 1.815 101.688 2.352
201609 1.845 101.861 2.387
201612 1.769 101.863 2.288
201703 1.772 102.862 2.270
201706 1.775 103.349 2.263
201709 1.770 104.136 2.240
201712 1.753 104.011 2.221
201803 1.737 105.290 2.174
201806 1.649 106.317 2.044
201809 1.481 106.507 1.832
201812 1.474 105.998 1.832
201903 1.508 107.251 1.853
201906 1.412 108.070 1.722
201909 2.623 108.329 3.191
201912 2.615 108.420 3.178
202003 2.527 108.902 3.058
202006 3.691 108.767 4.472
202009 3.918 109.815 4.702
202012 5.648 109.897 6.772
202103 5.724 111.754 6.750
202106 5.547 114.631 6.377
202109 5.360 115.734 6.103
202112 5.761 117.630 6.454
202203 5.653 121.301 6.141
202206 5.477 125.017 5.773
202209 5.545 125.227 5.835
202212 5.350 125.222 5.630
202303 5.328 127.348 5.513
202306 5.127 128.729 5.248
202309 4.895 129.860 4.967
202403 4.785 131.776 4.785

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Oneness Biotech Co  (LUX:ONEA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Oneness Biotech Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oneness Biotech Co (LUX:ONEA) Business Description

Traded in Other Exchanges
Address
No. 236, Section 4, Xinyi Road, 11th Floor, Daan District, Taipei, TWN, 106
Oneness Biotech Co Ltd is a Taiwan based biopharmaceutical company. The company develops healthcare drugs. Its products are used for chronic diabetic, dengue hemorrhagic fever, and Rheumatoid Arthritis. The company's operating segment includes New Drug Research and Development and Agricultural Products Cultivation. It generates maximum revenue from New Drug Research and Development segment.

Oneness Biotech Co (LUX:ONEA) Headlines

No Headlines